Philips vs STMicroelectronics
Side-by-side comparison of AI visibility scores, market position, and capabilities
Dutch health technology company with €17B revenue; MRI/CT imaging and patient monitoring managing massive sleep apnea device recall competing with Siemens Healthineers and GE HealthCare.
About
Philips is a Dutch multinational technology and health technology company that has transformed from a broad consumer electronics conglomerate into a focused health technology leader — producing diagnostic imaging systems (MRI, CT, ultrasound), patient monitoring, hospital informatics, personal health products (electric toothbrushes, shavers, sleep apnea devices), and health informatics solutions. Listed on the Amsterdam Stock Exchange (AEX: PHIA) and headquartered in Amsterdam, Philips generates approximately €17 billion ($18 billion) in annual revenue after divesting its lighting division (now Signify) and domestic appliances business.\n\nPhilips' health technology portfolio spans two segments: Diagnosis & Treatment (imaging systems, image-guided therapy, and ultrasound for hospitals) and Connected Care (patient monitoring, respiratory care, sleep therapy). The Diagnosis & Treatment segment provides MRI systems, CT scanners, and X-ray equipment to hospitals globally. The Connected Care segment includes Philips' DreamStation and other sleep apnea (CPAP/BiPAP) devices, home respiratory care, and hospital patient monitoring platforms.\n\nIn 2025, Philips is managing the severe consequences of a 2021 recall of approximately 5.5 million sleep apnea devices (Philips Respironics DreamStation and related models) due to concerns that degraded polyester foam could release harmful particles and gases — one of the largest medical device recalls in history. The recall has resulted in multi-billion dollar settlements, regulatory scrutiny, and significant reputation damage in the sleep therapy market, allowing competitors ResMed and Fisher & Paykel to gain share. Philips' 2025 strategy focuses on resolving recall liabilities, rebuilding the sleep therapy business, and investing in AI-powered diagnostic imaging to compete with Siemens Healthineers and GE HealthCare.
Franco-Italian semiconductor giant; ~$13B revenue. STM32 MCU family powers 4B+ IoT/embedded devices. Strong SiC power device position for automotive and industrial markets.
About
STMicroelectronics was formed in 1987 through the merger of Italy's SGS Microelettronica and France's Thomson Semiconducteurs in Geneva, Switzerland. The company has built a comprehensive portfolio spanning microcontrollers (MCUs), MEMS sensors, power management ICs, silicon carbide devices, and wireless connectivity chips serving automotive, industrial, IoT, and consumer electronics markets worldwide.\n\nSTMicro is perhaps best known for its STM32 family of ARM Cortex-M microcontrollers, which power billions of embedded applications from smart home devices and wearables to industrial controllers and medical devices. The company is also a major manufacturer of MEMS inertial sensors (accelerometers, gyroscopes) found in smartphones and automotive safety systems, and has a rapidly growing SiC power device business targeting EV inverters and industrial power converters. STMicro reported revenues of approximately $13 billion in FY2024 and guided for continued mid-to-high single digit growth in 2025 across most end markets.\n\nSTMicro operates 11 main manufacturing sites across Europe and Asia, giving it significant vertical integration and a degree of supply chain resilience. The company is jointly owned by French and Italian state entities holding approximately 27.5%, reflecting its strategic national significance. ST is expanding its Catania (Sicily) SiC manufacturing campus to meet surging EV demand and is a founding partner in multiple European semiconductor ecosystem initiatives.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.